Plasminogen activator inhibitor-1 is a significant determinant of renal injury in experimental crescentic glomerulonephritis

Journal of the American Society of Nephrology

Volumn 14, Issue 6, 2003, Pages 1487-1495

  Kitching, A Richard ^a,b   Kong, Yao Z ^a   Huang, Xiao Ru ^a   Davenport, Piers ^a   Edgtton, Kristy L ^a   Carmeliet, Peter ^b   Holdsworth, Stephen R ^a   Tipping, Peter G ^a,c  

^a MONASH UNIVERSITY   (Australia)

^b DEPARTMENT OF PLANT SYSTEMS BIOLOGY   (Belgium)

^c MONASH UNIVERSITY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

FIBRIN; PLASMIN; PLASMINOGEN; PLASMINOGEN ACTIVATOR INHIBITOR 1;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD CLOTTING; CONTROLLED STUDY; DISEASE MARKER; FIBRINOLYSIS; GENE OVEREXPRESSION; GLOMERULOSCLEROSIS; GLOMERULUS BASEMENT MEMBRANE; KIDNEY INJURY; LEUKOCYTE ADHERENCE; MOUSE; NEUTROPHIL CHEMOTAXIS; NONHUMAN; PRIORITY JOURNAL;

EID: 0038512474     PISSN: 10466673     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.ASN.0000065550.13931.00     Document Type: Article

References (40)

1. Neale TJ, Tipping PG, Carson SD, Holdsworth SR: Participation of cell-mediated immunity in deposition of fibrin in glomerulonephritis. Lancet 2: 421-424, 1988
2. Kincaid-Smith P: Coagulation and renal disease. Kidney Int 2: 183-190, 1972
3. Vassalli P, McCluskey RT: Pathogenetic role of the coagulation process in rabbit Masugi nephritis. Am J Pathol 45: 653-677, 1964
4. Holdsworth SR, Tipping PG: Macrophage-induced glomerular fibrin deposition in experimental glomerulonephritis in the rabbit. J Clin Invest 76: 1367-1374, 1985
5. Naish P, Penn GB, Evans DJ, Peters DK: The effect of defibrination on nephrotoxic serum nephritis in rabbits. Clin Sci 42: 643-646, 1972
6. Drew AF, Tucker HL, Liu H, Witte DP, Degen JL, Tipping PG: Crescentic glomerulonephritis is diminished in fibrinogen-deficient mice. Am J Physiol Renal Physiol 281: F1157-F1163, 2001
7. Erlich JH, Holdsworth SR, Tipping PG: Tissue factor initiates glomerular fibrin deposition and promotes major histocompatibility complex class II expression in crescentic glomerulonephritis. Am J Pathol 150: 873-880, 1997
8. Kitching AR, Holdsworth SR, Ploplis VA, Plow EF, Collen D, Carmeliet P, Tipping PG: Plasminogen and plasminogen activators protect against renal injury in crescentic glomerulonephritis. J Exp Med 185: 963-968, 1997
9. Angles-Cano E, Rondeau E, Delarue F, Hagege J, Sultan Y, Sraer JD: Identification and cellular localization of plasminogen activators from human glomeruli. Thromb Haemost 54: 688-692, 1985
10. Rerolle JP, Hertig A, Nguyen G, Sraer JD, Rondeau EP: Plasminogen activator inhibitor type 1 is a potential target in renal fibrogenesis. Kidney Int 58: 1841-1850, 2000
11. Eddy AA: Plasminogen activator inhibitor-1 and the kidney. Am J Physiol Renal Physiol 283: F209-220, 2002
12. Malliaros J, Holdsworth SR, Wojta J, Erlich J, Tipping PG: Glomerular fibrinolytic activity in anti-GBM glomerulonephritis in rabbits. Kidney Int 44: 557-564, 1993
13. Feng L, Tang WW, Loskutoff DJ, Wilson CB: Dysfunction of glomerular fibrinolysis in experimental antiglomerular basement membrane antibody glomerulonephritis. J Am Soc Nephrol 3: 1753-1764, 1993
14. Oda T, Jung YO, Kim HS, Cai X, Lopez-Guisa JM, Ikeda Y, Eddy AA: PAI-1 deficiency attenuates the fibrogenic response to ureteral obstruction. Kidney Int 60: 587-596, 2001
15. Thomson NM, Moran J, Simpson IJ, Peters DK: Defibrination with ancrod in nephrotoxic nephritis in rabbits. Kidney Int 10: 343-347, 1976
16. Tipping PG, Dowling JP, Holdsworth SR: Glomerular procoagulant activity in human proliferative glomerulonephritis. J Clin Invest 81: 119-125, 1988
17. Rondeau E, Mougenot B, Lacave R, Peraldi MN, Kruithof EK, Sraer JD: Plasminogen activator inhibitor 1 in renal fibrin deposits of human nephropathies. Clin Nephrol 33: 55-60, 1990
18. Moll S, Menoud PA, Fulpius T, Pastore Y, Takahashi S, Fossati L, Vassalli JD, Sappino AP, Schifferli JA, Izui S: Induction of plasminogen activator inhibitor type 1 in murine lupus-like glomerulonephritis. Kidney Int 48: 1459-1468, 1995
19. Keeton M, Ahn C, Eguchi Y, Burlingame R, Loskutoff DJ: Expression of type 1 plasminogen activator inhibitor in renal tissue in murine lupus nephritis. Kidney Int 47: 148-157, 1995
20. Carmeliet P, Kieckens L, Schoonjans L, Ream B, van Nuffelen A, Prendergast G, Cole M, Bronson R, Collen D, Mulligan RC: Plasminogen activator inhibitor-1 gene-deficient mice. I. Generation by homologous recombination and characterization. J Clin Invest 92: 2746-2755, 1993
21. Carmeliet P, Stassen JM, Schoonjans L, Ream B, van den Oord JJ, De Mol M, Mulligan RC, Collen D: Plasminogen activator inhibitor-1 gene-deficient mice. II. Effects on hemostasis, thrombosis, and thrombolysis. J Clin Invest 92: 2756-2760, 1993
22. Eitzman DT, McCoy RD, Zheng X, Fay WP, Shen T, Ginsburg D, Simon RH: Bleomycin-induced pulmonary fibrosis in transgenic mice that either lack or overexpress the murine plasminogen activator inhibitor-1 gene. J Clin Invest 97: 232-237, 1996
23. Kitching AR, Huang XR, Turner AL, Tipping PG, Dunn AR, Holdsworth SR: The requirement for granulocyte-macrophage colony-stimulating factor and granulocyte colony-stimulating factor in leukocyte-mediated immune glomerular injury. J Am Soc Nephrol 13: 350-358, 2002
24. Declerck PJ, Verstreken M, Collen D: Immunoassay of murine t-PA, u-PA and PAI-1 using monoclonal antibodies raised in gene-inactivated mice. Thromb Haemost 74: 1305-1309, 1995
25. Lijnen HR, Okada K, Matsuo O, Collen D, Dewerchin M: Alpha2-antiplasmin gene deficiency in mice is associated with enhanced fibrinolytic potential without overt bleeding. Blood 93:2274-2281, 1999
26. Tipping PG, Huang XR, Berndt MC, Holdsworth SR: A role for P selectin in complement-independent neutrophil-mediated glomerular injury. Kidney Int 46: 79-88, 1994
27. Huang XR, Holdsworth SR, Tipping PG: Evidence for delayed type hypersensitivity mechanisms in glomerular crescent formation. Kidney Int 46: 69-78, 1994
28. Bergman I, Loxley R: Two improved and simplified methods for the spectrophotometric determination of hyroxyproline. Anal Chem 35: 1961-1965, 1963
29. Holdsworth SR, Thomson NM, Glasgow EF, Atkins RC: The effect of defibrination on macrophage participation in rabbit nephrotoxic nephritis: Studies using glomerular culture and electron microscopy. Clin Exp Immunol 37: 38-43, 1979
30. Huang XR, Tipping PG, Shuo L, Holdsworth SR: Th1 responsiveness to nephritogenic antigens determines susceptibility to crescentic glomerulonephritis in mice. Kidney Int 51: 94-103, 1997
31. Kalluri R, Danoff TM, Okada H, Neilson EG: Susceptibility to anti-glomerular basement membrane disease and Goodpasture syndrome is linked to MHC class II genes and the emergence of T cell-mediated immunity in mice. J Clin Invest 100: 2263-2275, 1997
32. Kitching AR, Tipping PG, Holdsworth SR: IL-12 directs severe renal injury, crescent formation and Th1 responses in murine glomerulonephritis. Eur J Immunol 29: 1-10, 1999
33. Ploplis VA, French EL, Carmeliet P, Collen D, Plow EF: Plasminogen deficiency differentially affects recruitment of inflammatory cell populations in mice. Blood 91: 2005-2009, 1998
34. Edgtton KL, Carmeliet P, Kitching AR: Endogenous plasmin is not protective in unilateral ureteric ligation induced renal interstitial fibrosis. Nephrology 7: A 76, 2002
35. Kitching AR, Turner AL, Lijnen HR: Endogenous α2-antiplasmin does not enhance fibrin deposition or injury in glomerulonephritis. Nephrology 7: A76, 2002
36. Dewerchin M, Collen D, Lijnen HR: Enhanced fibrinolytic potential in mice with combined homozygous deficiency of alpha2-antiplasmin and PAI-1. Thromb Haemost 86: 640-646, 2001
37. Lacave R, Rondeau E, Ochi S, Delarue F, Schleuning WD, Sraer JD: Characterization of a plasminogen activator and its inhibitor in human mesangial cells. Kidney Int 35: 806-811, 1989
38. Xu Y, Hagege J, Mougenot B, Sraer JD, Ronne E, Rondeau E: Different expression of the plasminogen activation system in renal thrombotic microangiopathy and the normal human kidney. Kidney Int 50: 2011-2019, 1996
39. Duymelinck C, Dauwe SE, Nouwen EJ, De Broe ME, Verpooten GA: Cholesterol feeding accentuates the cyclosporine-induced elevation of renal plasminogen activator inhibitor type 1. Kidney Int 51: 1818-1830, 1997
40. Wang AY, Poon P, Lai FM, Yu L, Choi PC, Lui SF, Li PK: Plasminogen activator inhibitor-1 gene polymorphism 4G/4G genotype and lupus nephritis in Chinese patients. Kidney Int 59: 1520-1528, 2001